glp-1 drugs contraindications Diabetes mellitus: A number of drugs to treat diabetes mellitus have become available in recent years. Much research has focused around the role of glucagon-like peptide-1 (GLP-1), a hormone Glucagon-like Receptor-1 agonists for obesity:

E., Battaglia F., Hen R

It should also be taken into consideration that the treatment outcome after the GLP-1R agonists may be different for rats drinking alcohol or not, as alcohol consumption enhances traversing of the bloodbrain barrier (Rubio-Araiz et al., 2017)

Discontinuing semaglutide after weight loss: strategy for weight maintenance and a possible new side effect

Another meta-analysis of 21 RCTs involving 25,957 patients with T2DM, obesity, or overweight showed that semaglutide was associated with a lower risk of AF occurrence [29]

[DOI] [PubMed] [Google Scholar] 452.Girada S.B., Kuna R.S., Bele S., Zhu Z., Chakravarthi N.R., DiMarchi R.D